Cramer’s lightning round: Editas Medicine is not a buy

DraftKings Inc: “They are in a battle, a pure battle to try to get market share and right now, there is no sign that the battle is over. … I do think they’ll win.”

SoFi Technologies Inc: “I can’t tell you to sell it. But I can also tell you, maybe I’m not the answer on this stock because holy cow, it hasn’t stopped [going down in price] and I thought it would have.”

Editas Medicine Inc: “You can not buy growth stocks that have no hope of making money. Not in this environment.”

Altria Group Inc: “It is tobacco, and that’s not what I’m fond of. … If you don’t care, then it’s fine.”

Source

Business

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals

February 18, 2026

Food and Drug Administration Commissioner Marty Makary warned that the U.S. is falling behind China in early-stage drug development and called for reforms that could streamline the process for starting trials on new treatments. In an interview with CNBC on Wednesday, Makary specifically pointed to three bottlenecks that he said cause the U.S. to fall […]

Business

Seattle Seahawks begin sale process after Super Bowl win

February 18, 2026

Dareke Young #83 of the Seattle Seahawks celebrates with teammates during the third quarter of the NFC Championship game against the Los Angeles Rams at Lumen Field on Jan. 25, 2026 in Seattle, Washington. Jane Gershovich | Getty Images The Seattle Seahawks are officially up for sale. The NFL team, which defeated the New England […]

Business

FDA chief Marty Makary says ‘everything should be over the counter’ unless drug is unsafe or addictive

February 18, 2026

Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires monitoring – doubling down on a push that some in the pharmaceutical industry have questioned. In an interview Wednesday in Washington, D.C., Makary said the FDA aims to make […]